Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SciSparc (SPRC US)
Watchlist
83
Analysis
Health Care
•
Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
25 Mar 2026 07:36
•
Broker
Krungthai XSpring Zoom Eng. March 24, 2026
Trump signaled progress in US–Iran negotiations and ordered a five-day delay (expected until March 28) in attacks on Iran’s power plants and energy...
Krungthai XSpring
Follow
109 Views
Share
bearish
•
Cross Asset Strategy
•
15 Aug 2025 10:00
•
Broker
US PPI Jumps More Than Expected, Undermining Hopes for Fed Rate Cuts
The SET Index is expected to weaken today, with the support at 1,253/1,250 points (10-day EMA) and the resistance at 1,270/1,280 points. Overall,...
Krungthai XSpring
Follow
87 Views
Share
bullish
•
Cross Asset Strategy
•
14 Aug 2025 10:19
•
Broker
MPC Rate Cut Is Positive for Economy But Negative for Banking Sector
The SET Index is expected to be volatile today (rising with intermittent pullbacks), with the resistance at 1,280/1,292 points (EMA 75-week) and...
Krungthai XSpring
Follow
89 Views
Share
bullish
•
Kasikornbank
•
17 Sep 2026 11:08
•
Broker
Krungthai XSpring Zoom Eng. September 17, 2026
(+) Major Asian markets, including the NIKKEI and KOSPI, rose after the Fed raised interest rates as expected. We expect the SET to rebound and...
Krungthai XSpring
Follow
96 Views
Share
bearish
•
Cross Asset Strategy
•
05 Feb 2025 10:07
•
Broker
Global Services Reports for January, US Private Sector Employment, and Thai Inflation
Technically, the SET Index is expected to weaken, with the support at 1,292/1,285 points and resistance at 1,308/1,316 points. In the medium term,...
Krungthai XSpring
Follow
88 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x